MBL

IMMUNOCYTO CD107a Detection Kit

Product Code:
 
MBL-4844
Product Group:
 
Cell Based Assays
Supplier:
 
MBL
Regulatory Status:
 
RUO
Shipping:
 
4°C
Storage:
 
4°C
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
MBL-484450 Assays£430.00
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Description:
When T-cells and NK-cells recognize target cells, the contents of the lytic granules, including proteins such as perforin, granzymes and granulysin, are secreted by degranulation. CD107a, also known as lysosome-associated membrane protein 1 (LAMP-1), is a glycoprotein present in the membrane of cytotoxic granules. As a result of degradation by these lytic molecules, CD107 is exposed on the cell surface. Thus surface-exposed CD107 is a marker of secretion of the lytic granule contents, and the detection of CD107 exposed on the cell surface enables rapid assessment of cell-mediated cytotoxicity and detection of antigen specific cytotoxic T-cells. The ?CD107a mobilization assay? is the most commonly used method for detection of CD107a. In this method, the cells are cultured in the presence of CD107a monoclonal antibody after antigen stimulation, which enables sensitive detection of CD107a. The IMMUNOCYTO™ CD107a Detection kit is a reagent for detection of CD107a exposed on the cell surface after antigen stimulation by CD107a mobilization assay.
Gene IDs:
Human: 3916 Mouse: 16783
Kit Components:
FITC labeled anti-human CD107a monoclonal antibody, FITC labeled mouse IgG1 isotype control, Monensin, Cell suspension solution
Shelf Life:
see label
Target:
CD107a

Documents

References

1). Rubio V. et al, Nat Med, 9: 1337-82 (2003) 2). Betts MR. et al, J Immunol methods, 281: 65-78 (2003)